Showing 3381-3390 of 8921 results for "".
New Insights Into Azelaic Acid
https://practicaldermatology.com/topics/general-topics/new-insights-into-azelaic-acid/22948/As we learn more about this agent, we also discover new ways of understanding and approaching rosacea, acne, and hyperpigmentation.Check Your Financial Fitness
https://practicaldermatology.com/topics/practice-management/check-your-financial-fitness/23710/Take the steps to get your finances in shape—now and for the long term.Getting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.Wardrobe
Malfunctionhttps://practicaldermatology.com/topics/practice-management/wardrobe-malfunction/20913/Top dermatologists share tips on dressing for success.Challenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.Update on Diagnosis and Topical Management of Erythrasma
https://practicaldermatology.com/topics/general-topics/PD0909_03-php/22767/This under-diagnosed cutaneous infection is caused by a bacterium but may respond to anti-fungal therapies.An Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.Women in Dermatology With Doris Day, MD
https://practicaldermatology.com/columns/physician-spotlight/women-in-dermatology-with-doris-day-md/23236/Top Dermatology Marketing Trends for 2023
https://practicaldermatology.com/topics/practice-management/top-dermatology-marketing-trends-for-2023/23862/Are you up to date on trends in digital marketing?A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.